ETFs DaVita Inc.

DVA

US23918K1088

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 15:58:47 2026-01-15 EST			5-day change	1st Jan Change
105.80 ^USD	+1.85%		-5.92%	-6.76%

01-05	Truist Adjusts Price Target on DaVita to $128 From $140, Maintains Hold Rating	MT
01-05	Rockwell Medical, Inc. and DaVita, Inc. Enter into the Second Amendment to the Amended and Restated Products Purchase Agreement	CI

ETFs positioned on DaVita Inc.

Name	Varia. Jan 1.	Weight	AuM
AGF U.S. MARKET NEUTRAL ANTI-BETA FUND - USD	-3.89%	15.19%	303 M€
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED	0.00%	0.93%	2 M€
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	+1.01%	0.21%	26 M€
LYXOR MSCI USA ESG BROAD CTB (DR) UCITS ETF - DIST - EUR	-.--%	0.08%	1,006 M€
LYXOR MSCI USA ESG BROAD CTB (DR) UCITS ETF - ACC - EUR	-.--%	0.08%	0 M€
AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB UCITS ETF DR (C) - EUR	-.--%	0.07%	0 M€
AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB UCITS ETF DR (D) - EUR	-.--%	0.07%	0 M€
AMUNDI INDEX MSCI WORLD SRI PAB - UCITS ETF DR (C) - EUR	-.--%	0.05%	0 M€
AMUNDI INDEX MSCI WORLD SRI PAB - UCITS ETF DR - HEDGED EUR (C)	-.--%	0.05%	0 M€
CSIF (IE) MSCI USA ESG LEADERS BLUE UCITS ETF - B - USD	-.--%	0.04%	0 M€
AMUNDI MSCI USA ESG LEADERS SELECT - UCITS ETF DR (C) - USD	-0.28%	0.03%	0 M€
LYXOR MSCI USA ESG LEADERS EXTRA (DR) UCITS ETF - ACC - USD	-.--%	0.03%	0 M€
ADAPTIVE GROWTH OPPORTUNITIES ETF - USD	+5.15%	0.03%	324 M€

1 2 3

DaVita Inc. specializes in providing dialysis services. Net sales break down by activity as follows: - supply of dialysis services (95.7%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2024, services are insured through 2,657 dialysis centers serving nearly 200,800 patients in the United States, and through 509 dialysis centers serving nearly 80,300 patients abroad; - other (4.3%).

Employees

76,000

Sector

Healthcare Facilities & Services

Calendar

02-17 - Q4 2025 Earnings Release (Projected)

More about the company